IRIDEX Corp. engages in developing, manufacturing, and marketing medical systems, delivery devices, and consumable instrumentation for the ophthalmology market. The company is headquartered in Mountain View, California and currently employs 93 full-time employees. The firm is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Mr. Patrick Mercer es el President de IRIDEX Corp, se unió a la empresa desde 2018.
¿Qué tal es el rendimiento del precio de la acción IRIX?
El precio actual de IRIX es de $0.8402, ha aumentado un 0.07% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de IRIDEX Corp?
IRIDEX Corp pertenece a la industria Health Care y el sector es Health Care
¿Cuál es la capitalización bursátil de IRIDEX Corp?
La capitalización bursátil actual de IRIDEX Corp es $14.6M
¿Es IRIDEX Corp una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para IRIDEX Corp, incluyendo 0 fuerte compra, 0 compra, 3 mantener, 1 venta, y 0 fuerte venta